Постановление Правительства Московской области от 28.08.2012 № 1058/32

¦            ¦внедрения трансляционной       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦клеточной иммунотерапии и      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦селективных методов            ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гемокоррекции                  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.7       ¦Применение нормотермической    ¦Средства       ¦2013-2015 ¦   15168,8 ¦    4874,4 ¦    5147,2 ¦    5147,2 ¦                     ¦
¦            ¦перфузии с экстракорпоральной  ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мембранной оксигенацией крови у¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦асистолических доноров         ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.8       ¦Разработка и совершенствование ¦Средства       ¦2013-2015 ¦   14224,8 ¦    4571,0 ¦    4826,9 ¦    4826,9 ¦                     ¦
¦            ¦методов ранней диагностики и   ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦лечения тяжелого хирургического¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦сепсиса и эндотоксикоза с      ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦применением инновационных      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦методов экстракорпоральной     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гемокоррекции                  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.9       ¦Прогнозирование развития острых¦Средства       ¦2013-2015 ¦   12644,1 ¦    4063,1 ¦    4290,5 ¦    4290,5 ¦                     ¦
¦            ¦нарушений центральной          ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гемодинамики у больных в       ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦критическом состоянии          ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.10      ¦Послеоперационная когнитивная  ¦Средства       ¦2013-2015 ¦   37504,0 ¦   12051,6 ¦   12726,2 ¦   12726,2 ¦                     ¦
¦            ¦дисфункция у взрослых и детей: ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦эпидемиология, патогенез,      ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦профилактика и ранняя коррекция¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.11      ¦Разработка программы           ¦Средства       ¦2013-2015 ¦   12063,8 ¦    3876,6 ¦    4093,6 ¦    4093,6 ¦                     ¦
¦            ¦диагностики и лечения          ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦первичного гиперпаратиреоза у  ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦жителей Московской области     ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.12      ¦Разработка системы             ¦Средства       ¦2013-2015 ¦    7708,2 ¦    2477,0 ¦    2615,6 ¦    2615,6 ¦                     ¦
¦            ¦прогнозирования клинического   ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦течения, алгоритмов диагностики¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦и оптимизация лечения          ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦нейроэндокринных опухолей с    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦применением инновационных      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦технологий                     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.13      ¦Разработка инновационных       ¦Средства       ¦2013-2015 ¦    7814,2 ¦    2511,0 ¦    2651,6 ¦    2651,6 ¦                     ¦
¦            ¦технологий профилактики,       ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦диагностики и лечения сахарного¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦диабета и его осложнений       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.14      ¦Оптимизация методов диагностики¦Средства       ¦2013-2015 ¦    9061,1 ¦    2911,7 ¦    3074,7 ¦    3074,7 ¦                     ¦
¦            ¦и лечения гормонально-активных ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦опухолей гипофиза              ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦                               ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.15      ¦Оптимизация методов            ¦Средства       ¦2013-2015 ¦    9061,1 ¦    2911,7 ¦    3074,7 ¦    3074,7 ¦                     ¦
¦            ¦диагностики, профилактики и    ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦лечения системного остеопороза ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦и его осложнений               ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.16      ¦Оптимизация схем использования ¦Средства       ¦2013-2015 ¦    9061,1 ¦    2911,7 ¦    3074,7 ¦    3074,7 ¦                     ¦
¦            ¦глюкокортикоидов и разработка  ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦алгоритма комбинированного     ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦(консервативного и             ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦хирургического) лечения        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦эндокринной офтальмопатии,     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦сопровождающейся оптической    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦нейропатией и/или патологией   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦роговицы                       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.17      ¦Разработка и совершенствование ¦Средства       ¦2013-2015 ¦   10918,9 ¦    3508,7 ¦    3705,1 ¦    3705,1 ¦                     ¦
¦            ¦методов диагностики и лечения  ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦пациентов с первичной и        ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦вторичной легочной гипертензией¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.18      ¦Разработка новых методов       ¦Средства       ¦2013-2015 ¦   20254,0 ¦    6508,4 ¦    6872,8 ¦    6872,8 ¦                     ¦
¦            ¦профилактики, диагностики и    ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦лечения наиболее социально     ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦значимых неврологических       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦заболеваний на основе          ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦использования инновационных    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦технологий                     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.19      ¦Разработка тактики             ¦Средства       ¦2013-2015 ¦   17198,3 ¦    5526,5 ¦    5835,9 ¦    5835,9 ¦                     ¦
¦            ¦хирургического лечения         ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мультифокальных поражений с    ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦нарушением кровообращения в    ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦нескольких артериальных        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦бассейнах                      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.20      ¦Разработка и внедрение в       ¦Средства       ¦2013-2015 ¦   21659,2 ¦    6960,0 ¦    7349,6 ¦    7349,6 ¦                     ¦
¦            ¦клиническую практику           ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦комплексной многокомпонентной  ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦методики диагностики и         ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦хирургического лечения больных ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦инфекционным эндокардитом и    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦диспластическими заболеваниями ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦клапанного аппарата сердца     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.21      ¦Разработка инновационных       ¦Средства       ¦2013-2015 ¦   16974,0 ¦    5454,4 ¦    5759,8 ¦    5759,8 ¦                     ¦
¦            ¦технологий выявления           ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦предрасположенности к          ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гипертонической болезни у      ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦работников с вредными условиями¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦труда                          ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.22      ¦Научное обоснование комплекса  ¦Средства       ¦2013-2015 ¦    6494,3 ¦    2086,9 ¦    2203,7 ¦    2203,7 ¦                     ¦
¦            ¦мер по кадровому обеспечению   ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦Московской областной программы ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦государственных гарантий       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦оказания гражданам Российской  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦Федерации бесплатной           ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦медицинской помощи на основе   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мониторинга кадровых ресурсов  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦здравоохранения Московской     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦области                        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.23      ¦Анализ качества жизни и        ¦Средства       ¦2013-2015 ¦    6497,2 ¦    2087,8 ¦    2204,7 ¦    2204,7 ¦                     ¦
¦            ¦медико-социальных особенностей ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦заболеваемости медицинских     ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦работников, оказывающих        ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦специализированную медицинскую ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦помощь населению в медицинских ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦организациях Московской        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦области, профилактика          ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦заболеваний и формирование     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦здорового образа жизни         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.24      ¦Повышение эффективности лечения¦Средства       ¦2013-2015 ¦   21283,8 ¦    6839,4 ¦    7222,2 ¦    7222,2 ¦                     ¦
¦            ¦резистентных и осложненных форм¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦лейкозов, миелодиспластического¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦синдрома, тромбоцитопений с    ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦использованием инновационных   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦препаратов направленного       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦действия на основе создания,   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦функционирующих в режиме       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦реального времени, регистров   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦больных, включающих            ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦цитогенетический,              ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦молекулярно-биологический и    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦иммунологический мониторинг    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.25      ¦Разработка и совершенствование ¦Средства       ¦2013-2015 ¦   25444,7 ¦    8176,5 ¦    8634,1 ¦    8634,1 ¦                     ¦
¦            ¦методов ранней диагностики и   ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦лечения больных                ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦злокачественными эпителиальными¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦новообразованиями кожи,        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦саркомой Капоши, Т-клеточной   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦лимфомой кожи и аутоиммунными  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦дерматозами (истинная          ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦пузырчатка, склеродермия и др.)¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.26      ¦Повышение эффективности лучевой¦Средства       ¦2013-2015 ¦   17609,5 ¦    5658,7 ¦    5975,4 ¦    5975,4 ¦                     ¦
¦            ¦терапии местно-распространенных¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦форм злокачественных опухолей  ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦за счет целенаправленного      ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦применения радиомодификаторов и¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦использования комплекса        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦прогностических факторов       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.27      ¦Разработка методов оценки      ¦Средства       ¦2013-2015 ¦   10918,7 ¦    3508,7 ¦    3705,0 ¦    3705,0 ¦                     ¦
¦            ¦ранних маркеров легочного      ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦фиброза при саркоидозе и других¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦интерстициальных заболеваниях  ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦легких                         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.28      ¦Разработка прогностических     ¦Средства       ¦2013-2015 ¦   18951,3 ¦    6089,9 ¦    6430,7 ¦    6430,7 ¦                     ¦
¦            ¦критериев неблагоприятного и   ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦осложненного течения острых    ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦респираторных и кишечных       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦инфекций у детей               ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.29      ¦Особенности формирования       ¦Средства       ¦2013-2015 ¦   23524,7 ¦    7559,5 ¦    7982,6 ¦    7982,6 ¦                     ¦
¦            ¦заболеваний органов пищеварения¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦у детей с метаболическим       ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦синдромом, разработка          ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦научно-обоснованной программы  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦реабилитации больных и системы ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мониторинга эффективности      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦восстановительного лечения     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.30      ¦Разработка способов регенерации¦Средства       ¦2013-2015 ¦   19672,7 ¦    6321,7 ¦    6675,5 ¦    6675,5 ¦                     ¦
¦            ¦и реконструкции органов и      ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦тканей при хирургической       ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦патологии толстой кишки и      ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦органов репродуктивной системы ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦у детей                        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦(клинико-экспериментальное     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦исследование)                  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.31      ¦Применение высокообъемного     ¦Средства       ¦2013-2015 ¦    7668,6 ¦    2464,4 ¦    2602,1 ¦    2602,1 ¦                     ¦
¦            ¦плазмафереза в комплексной     ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦терапии гемолитико-уремического¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦синдрома у детей               ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.32      ¦Разработка методов диагностики,¦Средства       ¦2013-2015 ¦   25385,8 ¦    8157,6 ¦    8614,1 ¦    8614,1 ¦                     ¦
¦            ¦лечения и реабилитации больных ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦с дефектами мягких и костных   ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦тканей различной этиологии,    ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦атрофией альвеолярных отростков¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦челюстей, осложненными формами ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦верхнечелюстного синусита,     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦заболеваниями слюнных желез,   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦височно-нижнечелюстного сустава¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦и слизистой оболочки полости   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦рта с использованием           ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦эндоскопической и              ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦микрохирургической техники,    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦дентальной имплантации и       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦криохирургии                   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.33      ¦Совершенствование профилактики,¦Средства       ¦2013-2015 ¦   18884,7 ¦    6068,5 ¦    6408,1 ¦    6408,1 ¦                     ¦
¦            ¦ранней диагностики и лечения   ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦распространенных и             ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦инвалидизирующих дегенеративных¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦заболеваний сетчатки и         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦зрительного нерва              ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.34      ¦Разработка и усовершенствование¦Средства       ¦2013-2015 ¦   23627,9 ¦    7592,7 ¦    8017,6 ¦    8017,6 ¦                     ¦
¦            ¦новых медицинских технологий в ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦оториноларингологии и внедрение¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦их в клиническую практику      ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.35      ¦Разработка и совершенствование ¦Средства       ¦2013-2015 ¦   19695,0 ¦    6329,0 ¦    6683,0 ¦    6683,0 ¦                     ¦
¦            ¦методов микрохирургии: опухолей¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦головного мозга с применением  ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦нейронавигации и               ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦флюронавигации; нарушений      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мозгового кровообращения по    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦геморрагическому типу;         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦хирургического лечения         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦патологии головного, спинного  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мозга и позвоночника с         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦использованием эндоскопической ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦техники                        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.36      ¦Разработка дифференцированного ¦Средства       ¦2013-2015 ¦    9471,7 ¦    3043,7 ¦    3214,0 ¦    3214,0 ¦                     ¦
¦            ¦подхода к применению           ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦физико-фармакологических       ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦методов в системе медицинской  ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦реабилитации пациентов с       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦врожденной и приобретенной     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦патологией нервно-мышечного    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦аппарата и                     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦воспалительно-дегенеративными  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦заболеваниями с                ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦патофизиологическим            ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦обоснованием их применения     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.1.37      ¦Разработка и внедрение         ¦Средства       ¦2013-2015 ¦   36950,8 ¦   11874,0 ¦   12538,4 ¦   12538,4 ¦                     ¦
¦            ¦эффективных методик и тактики  ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦хирургического лечения         ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦осложнений после первичного    ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦эндопротезирования коленного и ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦тазобедренного суставов        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2         ¦Оказание работ по проведению   ¦               ¦2013-2015 ¦  253343,6 ¦   84847,6 ¦   84248,0 ¦   84248,0 ¦Министерство         ¦
¦            ¦научных исследований в области ¦               ¦          ¦           ¦           ¦           ¦           ¦здравоохранения      ¦
¦            ¦здравоохранения государственным¦               ¦          ¦           ¦           ¦           ¦           ¦Московской области   ¦
¦            ¦бюджетным учреждением          ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦здравоохранения Московской     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦области "Московский областной  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦научно-исследовательский       ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦институт акушерства и          ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гинекологии", в том числе по   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦темам:                         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.1       ¦"Совершенствование лечебной    ¦Средства       ¦2013-2015 ¦   67251,5 ¦   22266,1 ¦   22492,7 ¦   22492,7 ¦                     ¦
¦            ¦тактики у беременных с         ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гестационным сахарным диабетом ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦с целью снижения частоты       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гестационных осложнений и      ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦улучшения исходов для матери и ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦плода"                         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.2       ¦"Выявление клинических         ¦Средства       ¦2013-2015 ¦   53438,7 ¦   17012,1 ¦   18213,3 ¦   18213,3 ¦                     ¦
¦            ¦особенностей и нарушений       ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦процессов ранней неонатальной  ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦адаптации новорожденных,       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦родившихся у матерей с         ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦гестационным сахарным диабетом.¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦Разработка алгоритма           ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦диагностики и коррекции        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦нарушений адаптации у данного  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦контингента новорожденных"     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.3       ¦"Особенности формирования и    ¦Средства       ¦2013-2015 ¦   20751,9 ¦    6696,7 ¦    7027,6 ¦    7027,6 ¦                     ¦
¦            ¦функционирования системы       ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦мать-плацента-плод и лечебная  ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦тактика у женщин с             ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦эктрагенитальными заболеваниями¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦инфекционной этиологии"        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.4       ¦"Возможности реконструктивной  ¦Средства       ¦2013-2015 ¦   26193,0 ¦    7872,8 ¦    9160,1 ¦    9160,1 ¦                     ¦
¦            ¦хирургии матки в решении       ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦репродуктивных проблем"        ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦                               ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.5       ¦"Диагностика, лечение и        ¦Средства       ¦2013-2015 ¦   20767,6 ¦    6677,4 ¦    7045,1 ¦    7045,1 ¦                     ¦
¦            ¦реабилитация больных с         ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦выпадением женских половых     ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦органов"                       ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.6       ¦"Оптимизация тактики ведения   ¦Средства       ¦2013-2015 ¦   12754,9 ¦    3985,9 ¦    4384,5 ¦    4384,5 ¦                     ¦
¦            ¦пациенток с папилломовирусной  ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦инфекцией и пути ее            ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦профилактики"                  ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.7       ¦"Лечение бесплодия в браке:    ¦Средства       ¦2013-2015 ¦   26262,1 ¦   12065,9 ¦    7098,1 ¦    7098,1 ¦                     ¦
¦            ¦совершенствование              ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦диагностической и лечебной     ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦тактики, разработка новых      ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦направлений вспомогательных    ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦репродуктивных технологий"     ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.8       ¦"Внедрение и анализ результатов¦Средства       ¦2013-2015 ¦   13335,4 ¦    4274,2 ¦    4530,6 ¦    4530,6 ¦                     ¦
¦            ¦массового пренатального        ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦скрининга беременных в         ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦Московской области для         ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦диагностики хромосомных        ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦аномалий и врожденных пороков  ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦развития у плода"              ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦6.2.9       ¦"Оптимизация лечения           ¦Средства       ¦          ¦   12588,5 ¦    3996,5 ¦    4296,0 ¦    4296,0 ¦                     ¦
¦            ¦климактерических расстройств у ¦бюджета        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦женщин с миомой матки в        ¦Московской     ¦          ¦           ¦           ¦           ¦           ¦                     ¦
¦            ¦постменопаузе"                 ¦области        ¦          ¦           ¦           ¦           ¦           ¦                     ¦
+------------+-------------------------------+---------------+----------+-----------+-----------+-----------+-----------+---------------------+
¦            ¦Всего по разделу 6,            ¦               ¦          ¦  887754,0 ¦  296540,0 ¦  295607,0 ¦  295607,0 ¦                     ¦
¦            ¦в том числе:                   ¦               ¦          ¦           ¦           ¦           ¦           ¦                     ¦